These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29459178)

  • 1. The challenge of treating older patients with pancreaticobiliary malignancies.
    Corrigan LR; Bracken-Clarke DM; Horgan AM
    Curr Probl Cancer; 2018; 42(1):59-72. PubMed ID: 29459178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances for the treatment of pancreatic and biliary tract cancer after first-line treatment failure.
    Onesti CE; Romiti A; Roberto M; Falcone R; Marchetti P
    Expert Rev Anticancer Ther; 2015; 15(10):1183-98. PubMed ID: 26325474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase I study of eniluracil/5-FU in combination with radiation therapy for potentially resectable and/or unresectable cancer of the pancreas and distal biliary tract.
    Czito BG; Hong TJ; Cohen DP; Petros WP; Tyler DS; Pappas TN; Yu D; Lee CG; Lockhart AC; Morse MA; Fernando N; Hurwitz HI
    Cancer Invest; 2006 Feb; 24(1):9-17. PubMed ID: 16466986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoradiation for pancreatic and biliary cancer: current status of RTOG studies.
    Rich TA
    Ann Oncol; 1999; 10 Suppl 4():231-3. PubMed ID: 10436829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal cancer in the elderly.
    Wallach CB; Kurtz RC
    Gastroenterol Clin North Am; 1990 Jun; 19(2):419-32. PubMed ID: 2163983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodality Management of Localized Biliary Cancer.
    Ashai N; Prasad P; Rajdev L
    Curr Treat Options Oncol; 2019 May; 20(7):58. PubMed ID: 31144050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engaging the older cancer patient; Patient Activation through Counseling, Exercise and Mobilization - Pancreatic, Biliary tract and Lung cancer (PACE-Mobil-PBL) - study protocol of a randomized controlled trial.
    Mikkelsen MK; Lund CM; Vinther A; Tolver A; Ragle AM; Johansen JS; Chen I; Engell-Noerregaard L; Larsen FO; Zerahn B; Nielsen DL; Jarden M
    BMC Cancer; 2018 Sep; 18(1):934. PubMed ID: 30261853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant treatments for resectable pancreatic cancer.
    Ueno H; Kosuge T
    J Hepatobiliary Pancreat Surg; 2008; 15(5):468-72. PubMed ID: 18836798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicentre phase I-II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable pancreatic and biliary tract cancer: The CORGI-U study.
    Gunnlaugsson A; Anderson H; Lind P; Glimelius B; Johnsson A
    Radiother Oncol; 2010 Jun; 95(3):292-7. PubMed ID: 20451275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging treatment evolutions and integrated molecular characteristics of biliary tract cancers.
    Zhang R; Puzzoni M; Mariani S; Zheng Y; Liscia N; Guo Y; Donisi C; Liu Y; Impera V; Fang W; Scartozzi M
    Cancer Sci; 2021 Dec; 112(12):4819-4833. PubMed ID: 34534382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of radiation therapy in upper gastrointestinal cancers.
    Ilson DH
    Clin Adv Hematol Oncol; 2017 May; 15(5):366-376. PubMed ID: 28591092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic palliation of pancreaticobiliary malignancies.
    Shah JN; Muthusamy VR
    Gastrointest Endosc Clin N Am; 2005 Jul; 15(3):513-31, ix. PubMed ID: 15990055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPB cancers in older patients | inclusion of older/senior patients in clinical trials.
    Backen A; Lamarca A; Hubner RA; McNamara MG; Valle JW
    Eur J Surg Oncol; 2021 Mar; 47(3 Pt A):597-602. PubMed ID: 33298342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary malignancies of the hepato-biliary-pancreatic system in organ allograft recipients.
    Penn I
    J Hepatobiliary Pancreat Surg; 1998; 5(2):157-64. PubMed ID: 9745082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advances and Prospects for Multimodality Therapy in Pancreatic Cancer.
    Chadha AS; Khoo A; Aliru ML; Arora HK; Gunther JR; Krishnan S
    Semin Radiat Oncol; 2016 Oct; 26(4):320-37. PubMed ID: 27619253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The microbiome and hepatobiliary-pancreatic cancers.
    Mima K; Nakagawa S; Sawayama H; Ishimoto T; Imai K; Iwatsuki M; Hashimoto D; Baba Y; Yamashita YI; Yoshida N; Chikamoto A; Baba H
    Cancer Lett; 2017 Aug; 402():9-15. PubMed ID: 28527946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of HPB malignancy in the elderly.
    Pericleous M; Khan SA
    Eur J Surg Oncol; 2021 Mar; 47(3 Pt A):503-513. PubMed ID: 32360064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biliary Cancer: Current Multimodality Treatment and Future Directions.
    Copur MS; Merani S; Vargas LM
    Oncology (Williston Park); 2019 Sep; 33(9):. PubMed ID: 31571182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreaticobiliary malignancies: past, present, and future.
    Herman JM
    Semin Radiat Oncol; 2014 Apr; 24(2):61-6. PubMed ID: 24635862
    [No Abstract]   [Full Text] [Related]  

  • 20. Adjuvant Therapy for Biliary Tract Cancers.
    Horgan AM; Knox JJ
    J Oncol Pract; 2018 Dec; 14(12):701-708. PubMed ID: 30537458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.